ArticleJournal of thoracic disease2025
Evaluating mortality risk in elderly lung transplant patients.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung transplantation has greatly improved survival rates due to advances in surgery and care; however, data on mortality risks in elderly recipients remain limited. This study aimed to assess these risks. Methods: We conducted a cohort study using data from a single-institution lung transplant registry spanning January 2018 to December 2023. A comprehensive analysis was performed on the baseline characteristics and post-transplant complications, including infections and rejection. Results: A total of 337 lung transplantations were performed during the study period. Of these, elderly recipients (n=54) accounted for 16.0% and were less likely to undergo bilateral lung transplantation (25.9% Conclusions: These findings are indicative of advancements in lung transplantation and suggest that the current age-based eligibility standards merit re-evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.